Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
The Development of Prophylactic and Therapeutic EBV Vaccines.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Bi-Allelic TCRα or β Recombination Enhances T Cell Development but Is Dispensable for Antigen Responses and Experimental Autoimmune Encephalomyelitis.
Cognitive and psychiatric comorbidities in neuromyelitis optica.
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
MUNDUS project: MUltimodal Neuroprosthesis for daily Upper limb Support.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
[Molecular targeted therapy for neuroimmunological diseases].
Internal jugular veins out flow in patients with multiple sclerosis:a catheter venography study.
Panic disorder as presenting symptoms of multiple sclerosis.
Genomic medicine and risk prediction across the disease spectrum.
Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »